Fund III, raised in only three months, exceeded its $800 million target and represents a doubling from Fund II

Eir Partners Capital, LP (“Eir” or the “Firm”), a private equity firm focused on health tech and tech-enabled services, today announced the final close of Eir Partners III (“Fund III”). Fund III significantly exceeded the original capital target of $800 million, closing with aggregate capital commitments of $1 billion. Eir emphasizes long-term alignment with its limited partners by including a substantial GP commitment in each of its funds including Fund III.

Fund III was raised in only three months with the support of a diverse limited partner investor base of endowments, consultants, foundations, family offices, pension funds and insurance companies, including continued support from Eir’s long-time limited partners. The speed of this raise underscores the Firm’s 10-year history of making disciplined investments in companies across diverse healthcare sectors, including payer, provider, employer and pharma technology, that offer solutions in the healthcare technology sector.

Brett Carlson, Founder and Chief Executive Officer of Eir Partners, said, “Since our founding, regardless of market cycles, we have been able to execute deals and find unique ways to build strategic platforms that bring differentiated products to market. Our proven track record of scaling mid-stage growth businesses makes us an appealing partner for institutional investors that want exposure to the next generation of category leaders and disruptors. As we prepare to deploy Fund III, we are honored by the confidence and trust our limited partners have shown us and grateful to the new investors who have joined the Eir community.”

Since the Firm’s inception in 2015, Eir has completed more than 50 transactions across its 14 platform investments, a testament to the Firm’s deep network and long-standing relationships, a foundation that it believes will drive value in Fund III. To date, Eir has raised $1.8 billion, including its Eir Partners Investment Program II (“Fund II”) at $496 million in 2024 and its inaugural fund known as Eir Partners Investment Program I (“Fund I”) back in 2021, closing at $255 million.

Lazard Frères & Co. LLC acted as the exclusive placement advisor, and Cooley LLP served as legal counsel in the formation of Fund III.

About Eir Partners Capital, LP

Eir Partners Capital, LP is a Miami-based private equity company focused on healthcare technology and tech-enabled services. Founded in 2015, Eir has partnered with entrepreneurs and management teams to create scaled, strategically differentiated platforms across payer, provider, employer, and pharma technology sectors. The Firm’s hands-on approach combines operational insight with deep industry relationships to drive long-term value. Targeted stages of investment include growth equity through control buyouts and equity check sizes range from $40 - $150 million or larger with co-investments. For more information, please visit our website at www.eirpartners.com or our LinkedIn page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260108187123/en/